125 related articles for article (PubMed ID: 36281189)
21. Prognostic significance of lymph node ratio in node-positive cervical cancer patients.
Joo JH; Kim YS; Nam JH
Medicine (Baltimore); 2018 Jul; 97(30):e11711. PubMed ID: 30045335
[TBL] [Abstract][Full Text] [Related]
22. [Value of metastatic lymph node ratio in predicting the prognosis of non-small cell lung cancer patients].
Li Y; Sun BS; Zhang ZF; Zhang LM; Wang CL
Zhonghua Yi Xue Za Zhi; 2011 Jun; 91(24):1682-6. PubMed ID: 21914316
[TBL] [Abstract][Full Text] [Related]
23. Prognostic Value of Lymph Node Ratio in Breast Cancer Patients with Adequate Pathologic Evidence After Neoadjuvant Chemotherapy.
Ai X; Liao X; Wang M; Hu Y; Li J; Zhang Y; Tang P; Jiang J
Med Sci Monit; 2020 Apr; 26():e922420. PubMed ID: 32348295
[TBL] [Abstract][Full Text] [Related]
24. Role of lymph node yield and lymph node ratio in predicting outcomes in non-metastatic colorectal cancer.
Lee CHA; Wilkins S; Oliva K; Staples MP; McMurrick PJ
BJS Open; 2019 Feb; 3(1):95-105. PubMed ID: 30734020
[TBL] [Abstract][Full Text] [Related]
25. Lymph node ratio in inguinal lymphadenectomy for squamous cell vulvar cancer: Results from the AGO-CaRE-1 study.
Polterauer S; Schwameis R; Grimm C; Hillemanns P; Jückstock J; Hilpert F; de Gregorio N; Hasenburg A; Sehouli J; Fürst ST; Strauß HG; Baumann K; Thiel F; Mustea A; Harter P; Wimberger P; Kölbl H; Reinthaller A; Woelber L; Mahner S
Gynecol Oncol; 2019 May; 153(2):286-291. PubMed ID: 30760408
[TBL] [Abstract][Full Text] [Related]
26. [The relationship between the index of lymph node metastasis and the prognosis of pancreatic cancer patients after R0 resection].
Ren H; Wang CF
Zhonghua Zhong Liu Za Zhi; 2020 Jun; 42(6):474-479. PubMed ID: 32575943
[No Abstract] [Full Text] [Related]
27. Lymph Node Ratio: Is It an Independent Prognostic Factor for Stage III Cutaneous Melanoma?
Salari A; Nili F; Jalaeefar AM; Shirkhoda M
Asian Pac J Cancer Prev; 2018 Dec; 19(12):3623-3627. PubMed ID: 30583691
[TBL] [Abstract][Full Text] [Related]
28. [Prognostic value of metastatic axillary lymph node ratio in node-positive breast cancer treated by breast conserving surgery].
Zheng Y; Chen Q; Liang Z; Jia M; Cao X
Zhonghua Zhong Liu Za Zhi; 2015 Jan; 37(1):41-6. PubMed ID: 25877318
[TBL] [Abstract][Full Text] [Related]
29. Using the lymph nodal ratio to predict the risk of locoregional recurrence in lymph node-positive breast cancer patients treated with mastectomy without radiation therapy.
Wu SG; Chen Y; Sun JY; Li FY; Lin Q; Lin HX; He ZY
Radiat Oncol; 2013 May; 8():119. PubMed ID: 23672513
[TBL] [Abstract][Full Text] [Related]
30. Metastatic axillary lymph node ratio (LNR) is prognostically superior to pN staging in patients with breast cancer--results for 804 Chinese patients from a single institution.
Xiao XS; Tang HL; Xie XH; Li LS; Kong YN; Wu MQ; Yang L; Gao J; Wei WD; Xie X
Asian Pac J Cancer Prev; 2013; 14(9):5219-23. PubMed ID: 24175804
[TBL] [Abstract][Full Text] [Related]
31. [Positive lymph node ratio ≥0.16 is an independent risk factor affecting the prognosis of patients with esophageal cancer].
Yao W; Lu N; Cui M; Wang J; Du Z; Zhang M
Nan Fang Yi Ke Da Xue Xue Bao; 2020 Jun; 40(6):837-842. PubMed ID: 32895212
[TBL] [Abstract][Full Text] [Related]
32. Prognostic role of the lymph node ratio in node positive colorectal cancer: a meta-analysis.
Zhang MR; Xie TH; Chi JL; Li Y; Yang L; Yu YY; Sun XF; Zhou ZG
Oncotarget; 2016 Nov; 7(45):72898-72907. PubMed ID: 27662659
[TBL] [Abstract][Full Text] [Related]
33. Clinical Influence of the Lymph Node Ratio on Lymph Node Metastasis-positive Gastric Cancer Patients Who Receive Curative Treatment.
Aoyama T; Komori K; Tamagawa A; Nakazano M; Hara K; Hashimoto I; Tamagawa H; Segami K; Maezawa Y; Kano K; Oshima T; Yukawa N; Rino Y
In Vivo; 2022; 36(2):994-1000. PubMed ID: 35241561
[TBL] [Abstract][Full Text] [Related]
34. Efficacy of capecitabine and oxaliplatin versus S-1 as adjuvant chemotherapy in gastric cancer after D2 lymph node dissection according to lymph node ratio and N stage.
Shin K; Park SJ; Lee J; Park CH; Song KY; Lee HH; Seo HS; Jung YJ; Park JM; Lee SH; Roh SY; Kim IH
BMC Cancer; 2019 Dec; 19(1):1232. PubMed ID: 31852475
[TBL] [Abstract][Full Text] [Related]
35. [Clinical study on the effects of neoadjuvant chemotherapy on lymph node ratio, prognosis, and survival analysis of stage ⅢA-N2 non-small cell lung cancer].
Wei YL; Cui YH; Dong YH; Shi WJ
Zhonghua Yi Xue Za Zhi; 2021 Jan; 101(4):259-264. PubMed ID: 33486934
[No Abstract] [Full Text] [Related]
36. Association Between Lymph Node Ratio and Recurrence and Survival Outcomes in Patients With Oral Cavity Cancer.
Ding D; Stokes W; Eguchi M; Hararah M; Sumner W; Amini A; Goddard J; Somerset H; Bradley C; McDermott J; Raben D; Karam SD
JAMA Otolaryngol Head Neck Surg; 2019 Jan; 145(1):53-61. PubMed ID: 30452499
[TBL] [Abstract][Full Text] [Related]
37. Value of the metastatic lymph node ratio for predicting the prognosis of non-small-cell lung cancer patients.
Wang CL; Li Y; Yue DS; Zhang LM; Zhang ZF; Sun BS
World J Surg; 2012 Feb; 36(2):455-62. PubMed ID: 22187129
[TBL] [Abstract][Full Text] [Related]
38. Lymph node ratio is more predictive than traditional lymph node stratification in lymph node positive invasive breast cancer.
Bai LS; Chen C; Gong YP; Wei W; Tu Y; Yao F; Li JJ; Wang LJ; Sun SR
Asian Pac J Cancer Prev; 2013; 14(2):753-7. PubMed ID: 23621232
[TBL] [Abstract][Full Text] [Related]
39. Is Lymph Node Ratio a Prognostic Factor for Patients With Oral Squamous Cell Carcinoma?
Yamagata K; Fukuzawa S; Kanno N; Uchida F; Yanagawa T; Bukawa H
J Oral Maxillofac Surg; 2019 Jul; 77(7):1510-1519. PubMed ID: 30822404
[TBL] [Abstract][Full Text] [Related]
40. Lymph node ratio-dependent prognosis stratification and postoperative radiotherapy utilization in T1-2N1 oral cavity carcinoma.
Wang J; Liu Y; Shayan G; Ma Y; Yi J
Radiother Oncol; 2022 Jul; 172():83-90. PubMed ID: 35568286
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
